98%
921
2 minutes
20
Unlabelled: Subclinical mastitis is an asymptomatic inflammatory condition that can be difficult to define and diagnose. In the dairy industry, subclinical mastitis is diagnosed by milk somatic cell counts (SCCs) of ≥250,000 cells mL. In this pilot study, we assessed the efficacy of this index to identify human subclinical mastitis by comparing SCC levels with the inflammatory response [interleukin-8 (IL-8) levels] in 37 samples from asymptomatic and 10 clinical mastitis (CM) lactating women. The milk microbiota was determined by 16S rRNA gene sequencing. The SCC of CM samples ranged from 310,000 to 6,600,000 cells mL. However, 14 of 37 (37.8%) asymptomatic samples had high SCC (250,000-460,000 cells mL), indicating subclinical mastitis. SCC levels significantly ( < 0.001) and positively correlated with milk IL-8 levels reflecting the escalating inflammatory response across subclinical and clinical mastitis samples. Samples with an SCC of ≥250,000 cells mL showed significant increases in IL-8 responses when compared with milk samples from healthy women. The milk microbiome of CM samples was dominated by streptococcal and staphylococcal species (89.9% combined median relative abundance). In contrast, the combined median streptococcal/staphylococcal relative levels were 75.4% and 66.3% in milks from asymptomatic (subclinical mastitis) and healthy groups, respectively. The genus was increased in samples with an SCC of ≥250,000, although this should be interpreted with caution. Thus, the index of ≥250,000 somatic cells mL could be a reliable indicator of subclinical mastitis in humans and should aid future studies investigating the impact of subclinical mastitis on maternal health, breastfeeding behaviors, infant health, and development.
Importance: This pilot study suggests that SCC at a level of (greater than or equal to) 250,000 cells mL, as used in the dairy industry, is a suitable index to identify asymptomatic subclinical mastitis in lactating women since it reflects a significant increase in the inflammatory response compared to milk samples from healthy women. Using this index should aid studies into the short- and long-term consequences of subclinical mastitis for mother and infant.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11448179 | PMC |
http://dx.doi.org/10.1128/spectrum.04051-23 | DOI Listing |
Front Cell Infect Microbiol
September 2025
Unit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa.
Introduction: are commonly found in intramammary infections associated with bovine subclinical mastitis in dairy cattle, yet their genomic diversity and antimicrobial resistance dynamics remain poorly characterized, particularly in African settings.
Methods: This study presents a comparative genomic analysis of 17 isolates from South Africa, including five newly sequenced bovine mastitis strains and twelve porcine-derived genomes retrieved from GenBank. analysis using multilocus sequence typing (MLST), virulence genes, antibiotic resistance genes and plasmids replicon types were used to characterise these isolates.
Vet Clin North Am Food Anim Pract
September 2025
Department of Animal Science, Colorado State University, 350 West Pitkin Street, Fort Collins, USA. Electronic address:
The current article describes select nutritional metabolic disorders that can impact the health and well-being of beef and dairy cattle. These include: Subclinical or clinical acidosis that can lead to rumen, hind gut, or systemic acidosis. Acidosis can disrupt epithelial barrier function in the rumen and hindgut, enabling bacteria to enter the portal vein and form liver abscesses.
View Article and Find Full Text PDFFront Vet Sci
August 2025
Tranditional Chinese Veterinary Medicine Laboratory, College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.
Background: This study addresses the global challenge of subclinical bovine mastitis (SCBM) in dairy cows, a prevalent disease causing substantial economic losses, by investigating the mechanistic basis of , a traditional herbal remedy with empirically validated efficacy but incompletely understood modes of action.
Methods: Initially, the active components of were identified using LC-MS/MS. Dose-response trials were conducted in Holstein cows ( = 24 SCBM cases; = 6 healthy controls), along with multi-omics integration, including 16S rRNA sequencing for rumen/feces microbiota and UHPLC-MS metabolomics for serum analysis.
Pathogens
July 2025
Centre for Antimicrobial Resistance, Alberta Health Services/Alberta Precision Laboratories/University of Calgary, Calgary, AB T2N 4N1, Canada.
Water buffalo () are a primary source of milk in Pakistan, where bovine mastitis is a significant health issue among cattle, leading to substantial economic losses. is a predominant pathogen associated with mastitis; however, a detailed molecular characterization of the strains in the country remains limited. We previously characterized mastitis strains from the Hazara division of Khyber Pakhtunkhwa, Pakistan.
View Article and Find Full Text PDFMicroorganisms
August 2025
Institute of Animal Science and Veterinary Medicine, Wuhan Academy of Agricultural Sciences, Wuhan 430208, China.
Mastitis is a common disease for dairy cows that exerts tremendously detrimental impacts on the productivity of cows and economic viability of pasture. Dihydromyricetin (DMY) is a flavonoid monomeric compound that possesses anti-inflammatory and antioxidant activity. This study aimed at dissecting the effects of DMY on the lactation performance, blood parameters, gut microbiota, and metabolite profiles of dairy cows with subclinical mastitis (SM).
View Article and Find Full Text PDF